About Compass Therapeutics, Inc. 
Compass Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 33 Schemes (11.56%)
Foreign Institutions
Held by 50 Foreign Institutions (6.3%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-18 Million
Pharmaceuticals & Biotechnology
USD 974 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.05
-31.39%
4.65






